X-37
PrivateLast Round
Series A
Nov 14, 2019
Total Funding Raised
$14.5M
Company Overview
X-37 is a drug discovery and artificial intelligence & machine learning company that develops drugs for cancer, autoimmune diseases, and anticoagulation using AI technology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
AI drug discoverysmall molecule discoverytechbioundruggable targetspreclinical developmentcomputational drug discoveryAIDDdrug pipeline developmentbiotech out-licensingpharma partnershipsvirtual biotechprotein targets
Historical Pricing
Historical view of private secondary pricing and transaction trends.
X-37 Comps
Public and private peers based on sector, stage, and business model.
X-37 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 14, 2019 |
X-37 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCVC Bio | Series A |
| Hemi Ventures | Series A |
| Alpha Intelligence Capital | Series A |
X-37 Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about X-37's valuation, stock price, and market status.
Firmographic Details
HeadquartersSouth San Francisco, California
Year Founded2018
Last FundingNov 14, 2019